These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10326054)

  • 1. Relation between experimental and non-experimental study designs. HB vaccines: a case study.
    Jefferson T; Demicheli V
    J Epidemiol Community Health; 1999 Jan; 53(1):51-4. PubMed ID: 10326054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for preventing hepatitis B in health-care workers.
    Jefferson T; Demicheli V; Deeks J; MacMillan A; Sassi F; Pratt M
    Cochrane Database Syst Rev; 2000; (2):CD000100. PubMed ID: 10796693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
    Nevens F; Zuckerman JN; Burroughs AK; Jung MC; Bayas JM; Kallinowski B; Rivas EF; Duvoux C; Neuhaus P; Saliba F; Buti M; Zarski JP; Pons F; Vanlemmens C; Hamtiaux V; Stoffel M
    Liver Transpl; 2006 Oct; 12(10):1489-95. PubMed ID: 16964595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priorities and challenges for hepatitis B control in the Philippines and the importance of a vaccine dose at birth.
    Ruff TA; Bravo L; Gatchalian SR; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):972-90. PubMed ID: 19842381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study.
    Zuckerman JN; Sabin C; Craig FM; Williams A; Zuckerman AJ
    BMJ; 1997 Feb; 314(7077):329-33. PubMed ID: 9040320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
    Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain].
    González López A; Arístegui Fernández J; Díez-Delgado J; Dal-Ré Saavedra R
    An Esp Pediatr; 1998 Feb; 48(2):132-7. PubMed ID: 9577019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.
    Wood RC; MacDonald KL; White KE; Hedberg CW; Hanson M; Osterholm MT
    JAMA; 1993 Dec 22-29; 270(24):2935-9. PubMed ID: 8254853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatitis B infections: vaccination and its limitations.
    Leroux-Roels G; Cao T; De Knibber A; Meuleman P; Roobrouck A; Farhoudi A; Vanlandschoot P; Desombere I
    Acta Clin Belg; 2001; 56(4):209-19. PubMed ID: 11603250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Booster dose vaccination for preventing hepatitis B.
    Poorolajal J; Mahmoodi M; Haghdoost A; Majdzadeh R; Nasseri-Moghaddam S; Ghalichi L; Fotouhi A
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008256. PubMed ID: 21069704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.